Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lurbinectedin

EU orphan designation number: EU/3/12/1053   
Active ingredient: Lurbinectedin
Indication: Treatment of ovarian cancer
Sponsor: Pharma Mar S.A.
Avda de los Reyes 1, Polígono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/10/2012 Centralised Orphan - Designation EMA/OD/099/12 (2012)7230 of 10/10/2012